ArticleMikrochimica acta2019
An electrochemiluminescence immunosensor for myoglobin using an indium tin oxide glass electrode modified with gold nanoparticles and platinum nanowires.
Article in Mikrochimica acta, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Essential information about nanotechnology in cardiology.Annals of medicine and surgery (2012) · 2025Review
- Nanoscale Technologies in Highly Sensitive Diagnosis of Cardiovascular Diseases.Frontiers in bioengineering and biotechnology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
An electrochemiluminescence (ECL) immunosensor was fabricated to detect myoglobin in human serum. Specifically, gold nanoparticles and platinum nanowires were deposited onto indium tin oxide-coated glass with 3-aminopropyl-trimethoxysilane as the linker to fabricate a basal electrode. The gold nanoparticles had a diameter of approximately 5 nm, and the platinum nanowires had diameters of approximately 2-3 nm and lengths on the order of dozens of nanometers. The nanomaterials effectively enhanced the ECL of luminol and enabled it to emit strong light, even in a weakly basic environment. A myoglobin antibody was then covalently immobilized on the electrode. Upon formation of the immunocomplex, the intensity of the luminol ECL was reduced. Under the optimized experimental conditions, the intensity of the ECL linearly decreased with the logarithm of the myoglobin concentration over the range of 3.0 ng·mL
Indexed as
Identifiers
31376022What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.